Background. In chronic pediatric patients treated with intermittent hemodialysis (IHD), blood volume monitoring (BVM) is commonly used to assess and manage volume status during the dialysis session. Minimal data exists on its use during IHD in critically ill children with acute kidney injury (AKI). In these cases, fluid removal may be limited by hemodynamic instability. Methods. We present a retrospective study conducted in our pediatric intensive care unit. For eligible patients, demographic data and IHD treatment characteristics were recorded including BVM use, ultrafiltration (UF) volume per session, hypotensive episodes and intradialysis interventions. Hypotensive episodes and UF per IHD session were compared between IHD sessions with BVM (BVM group) and IHD sessions without BVM (control group). Results. Twenty-three AKI patients with a median age of 11 years (1.8-18) and body weight of 36 kg (10-85) received 134 IHD sessions (70 with BVM and 64 without BVM). Hypotensive episodes occurred in 34% of all sessions with no significant difference between the BVM group and the control group: (95% CI: 22%, 44%) and 36% (95% CI: 24%, 48%), respectively, but UF per session was higher in the BVM group as compared to control (48 6 27 mL/kg and 33 6 26 mL/kg, respectively, P ¼ 0.0001). The mean decrease in BVM did not exceed 13% over an entire dialysis session in patients without hypotension. Conclusion. In conclusion, in our experience of IHD sessions in critically ill children with AKI, the use of BVM allowed a higher UF in those with BVM without influencing the frequency of hypotensive episodes. Applying specific guidelines on BVM use may decrease hypotensive episodes during IHD treatment in critically ill patients.
Introduction
Acute kidney injury (AKI) is common in patients hospitalized in a pediatric intensive care unit (PICU). Major causes include hemolytic uremic syndrome and ischemic acute tubular necrosis [1, 2] .
The choice of the renal support method in PICU patients depends mainly upon the clinical circumstances, the location and expertise available. Many authors recommend the use of continuous extrarenal therapies, such as hemofiltration, rather than intermittent hemodialysis (IHD) to minimize hypotensive episodes when patients have preexisting hemodynamic instability [3] [4] [5] . During IHD, ultrafiltration (UF), osmolar shifts and temperature changes can exacerbate hemodynamic instability and induce premature termination of the dialysis leading to decreased fluid and solute removal [6] . Recommendations to minimize hypotensive episodes include, slow fluid removal, daily dialysis sessions and high sodium concentration in the dialysate [7, 8] . However, despite all these strategies, the incidence of this complication is still high, occurring in 15-50% of dialysis sessions [9] [10] [11] .
Devices developed to monitor intradialytic changes in blood volume have been used to minimize intradialytic hypotension [12] [13] [14] . They have been widely used to manage fluid balance in chronic patients on IHD [14] [15] [16] [17] [18] [19] . No data exists on intradialytic blood volume monitoring (BVM) in critically ill children.
We report our experience with the use of BVM during IHD sessions in critically ill children with AKI.
Patients and methods

Patients
We conducted a single-center study to assess the impact of BVM use on hypotensive episodes and UF rates in a cohort of critically ill children requiring IHD for AKI. The study population consisted of all patients admitted to the PICU at Sainte-Justine Hospital, Montreal, between 1 January 2000 and 31 December 2007. The children were included in the study if they fulfilled the following criteria: (i) age between 1 and 18 years, (ii) AKI [20] and (iii) treated by IHD. The exclusion criteria were (i) pregnant adolescent, (ii) IHD for inherited metabolic diseases, (iii) children who were already on IHD prior to PICU admission and (iv) BVM hemodialysis sessions with red blood cell transfusion. The rationale for IHD instead of a continuous dialysis procedure in our unit refers to none or low dose of vasopressors.
IHD management
All patients were hemodialyzed at bedside using a Fresenius 2008 K machine (Fresenius, Bad Homburg, Germany) with a bicarbonate and a dialysate temperature of 37°C. The priming extracorporeal volume was based on saline infusion if body weight was >10 kg and saline infusion plus red blood cells if body weight was 10 kg.
Dialyzer choice was based on the priming volume and maximum flow rate with a surface that did not exceed the patient's body surface area and a urea clearance between 3 and 5 mL/kg/min. Filters were all biocompatible-based membranes. The pump was set to 6-8 mL/kg/min depending on the quality of the vascular access. Sodium in the dialyzate was either neutral, defined as time average sodium of 138 mEq/L, or profiled with decrease of dialyzate sodium concentration. UF rate was prescribed with no profiling and was modified by the dialysis nurse according to the hemodynamic status of the patient.
Heparin-free or heparin-based anticoagulation were used according to the clinical context, and vascular access consisted of a double lumen catheter [21] . Information on blood pressure, heart rate, hemodialysis settings, modification in IHD prescription and the reason for this modification was recorded every 15 min by the dialysis nurse. In ICU patients, the collection of information on cardiovascular status and hemodialysis regime modifications were recorded from the patient-monitoring devices every 15 min and no differences in the surveillance protocol between both groups occurred.
Hemodialysis sessions with BVM
After 2004, Fresenius hemodialysis machines with integrated blood volume monitors based on the measurement of evolution of the hematocrit during the dialysis session were introduced.
Between 2004 and 2007, BVM was not routinely used in IHD resulting in IHD sessions with BVM and others without. The dialysis nurses running the IHD sessions were able to use BVM values to adapt UF rate, if available, but no specific prescription on BVM thresholds was made in the absence of experience in critically ill children.
Data collection
A case report form was developed to collect patient demographic data, patient characteristics at admission and at first IHD treatment and IHD treatment data. Case report forms were filled out with data extracted from the hospital chart. IHD treatment data included initial dialysis prescription (type of filter, flow rates, duration, UF volume, sodium dialyzate concentration and temperature), the use of BVM, red blood cell transfusion, hypotensive episodes and any intervention during IHD. A hypotensive episode was defined as a systolic blood pressure <5th percentile adjusted for age and gender [22] . Interventions recorded included UF rate decrease, cessation of UF, saline bolus and early termination of dialysis run.
This study was approved by the research ethics board of Sainte-Justine hospital.
Data analysis Descriptive statistics. Descriptive statistics were used to report baseline patient characteristics. Results are presented as the median (25-75th interquartile ranges) or mean with SD.
Comparison of BVM group to controls. IHD treatments were divided into two groups. The BVM group consisted of IHD treatment with BVM. The control group consisted of IHD treatment without BVM.
The percentage of IHD treatments with hypotensive episodes, the percentage of IHD treatments with intervention in the absence of hypotension and UF volume achieved per treatment were compared between BVM group and control group using chi-squared test for categorical variables and Wilcoxon test for continuous variables. A multivariate regression (analysis of variance) was used to adjust UF volume for sodium profiling. Results were considered statistically significant at a P-value <0.05. The SAS System for Windows version 9.2 (SAS Institute Inc., Cary, NC) was used for all analyses.
Results
Twenty-three consecutive patients with a median age of 11 years (range 2-18 years) and body weight of 36 kg (range 10-85 kg) were included. At IHD initiation, 12/23 were mechanically ventilated; 6/23 children had inotropic or vasopressor support, 17/23 had no vasopressors or low inotropes and vasopressor scores ( Table 1) .
The principal cause of AKI was acute tubular necrosis. Twelve patients survived to hospital discharge. One patient was still on dialysis after hospital discharge ( Table 1) .
The twenty-three patients had 134 IHD treatments: 64 in the control group and 70 in the BVM group. Three of the 23 children had at least one IHD treatment with BVM and one IHD treatment without BVM. The other 20 had either IHD treatment with BVM or IHD treatment without BVM. There was no significant difference in age, PELOD (pediatric logistic organ dysfunction) score and vasoactive score between IHD treatment control group and BVM group. Hypotensive episodes occurred in 34% (46/134) of all IHD treatments ( Table 2 ). The frequency of hypotensive episodes was similar between the BVM group [33%(95% CI: 22%,44%)] and the control group [36% (95% CI: 24%, 48%)], but mean UF was significantly higher in the BVM group (48 AE 27 versus 33 AE 26 mL/kg; P < 0.001) ( Table 2) .
Sub-group analysis.
There was a significant increase in the frequency of interventions in hypotension-free IHD treatments between the control group and the BVM group with respective values of 9.4 and 34.3% (P < 0.01). This increase was associated with a higher mean UF in the BVM group (Table 2) . When adjusting on sodium profiling, the UF difference between the two groups remained highly significant (P ¼ 0.008).
When comparing patients with and without hypotension in the BVM group, IHD treatments with hypotension had a steeper decrease of BVM compared with those without hypotension. In the latter, the mean decrease in BVM did not exceed 13% during IHD treatments (Figure 1 ).
Discussion
This is the first study to assess BVM during IHD in critically ill children with AKI. Intradialytic hypotension was observed in 34% of all IHD treatments in these patients. No difference was found in the frequency of hypotension when comparing patients with or without BVM (33 and 36%, respectively). However, in the BVM group, a higher degree of UF was achieved as compared with controls.
The incidence of intradialytic hypotensive episodes observed in our study was similar to the incidence reported in critically ill patients in the literature [6, 10, 26, 27] . Intradialytic hypotension is the result of the cardiovascular response to the reduction in blood volume during UF; and it is prevented by the mobilization and refilling of fluid from the interstitium space to the vascular space [28] [29] [30] [31] [32] [33] [34] . In critically ill patients, the refilling rate is decreased due to increased vascular permeability and extravasation of fluids and proteins resulting in hypovolemia and hypoproteinemia [35, 36] . To assess blood volume continuously during dialysis, BVM devices have been implemented by most manufacturers in their dialysis machine [37] . They do not provide absolute values of blood volume but continuous measurement of the percentage of blood volume change based on the concentration of hemoglobin. If UF rate exceeds refilling rate, blood volume contraction occurs and BVM values decrease [14, 22, 38] . By visualizing the inability of the extracellular compartment to refill, adjustments can be made including a decrease or cessation of UF rate. In our study, the dialysis nurses were running IHD based on continuous monitoring of blood pressure and heart rate in the control group and with these parameters plus BVM in the BVM group. We have shown that during IHD in critically ill children with AKI, BVM use was associated with higher UF volumes and a significant increase of interventions when compared to a control group. This was probably due to the fact that nurses used BVM information not only to adjust UF rate but also to give presumably small intravenous replacement fluid 
Survival to PICU discharge (n) 1 5 6 1 1 Survival to hospital discharge (n) 1 2 5 9 Dialysis after hospital discharge (n) 1 1 0 a PIM 2 score is a pediatric index of mortality at admission [23] , vasoactive score takes into account the amount of vasopressors and inotrope used [24] and PELOD score quantifies the degree of organ dysfunction (10 points corresponds to one organ dysfunction) [25] . b Three patients had IHD sessions both with and without BVM. amounts in a preventive way. This is also shown in Figure 1 with a steeper decrease of relative blood volume during IHD treatments. A strategy aiming to maintain BVM values in a dedicated range may decrease the incidence of hypotensive episodes. In our experience, the skilled nephrology nurses running the IHD sessions were able to use BVM values to adapt UF rate, so that the mean decrease in BVM did not exceed 13% over the entire dialysis sessions in patients who did not develop hypotension (Figure 1 ). The similar rate of hypotensive episodes between the BVM group and the control group may be due to attempts to achieve prescribed UF rates, with UF being decreased or ceased only when a hypotensive episode occurred. Nevertheless, in the BVM group, patients were able to obtain a higher degree of UF ( Table 2) . The strength of our study is the large number of IHD treatments studied. These results support the use of BVM at the bedside in the PICU. Our study has some limitations including its retrospective nature and the single-center experience. Practice may have changed between 2000 and 2007 resulting in an increase of UF volume per session independent of BVM use. This bias is probably of limited impact on our study as only 8/23 patients were treated before 2004 (Table 1) , and patient characteristics were similar between the control and BVM groups. Each IHD treatment was considered as an independent treatment although some children (3/25) had dialysis treatments both with and without BVM. The small number of such patients probably did not influence the results. In the present study, hypotensive episodes were only reported once per IHD treatment. We did not assess if there was a decrease or not in the absolute number of hypotensive episodes during IHD treatments. Nevertheless, the higher UF obtained in the BVM group suggests that either hypotensive episodes were delayed or were less severe in this group in comparison with the control group ( Table 2) .
Conclusions
In critically ill patients, hemodynamic instability is common and may be further worsened by the initiation of renal replacement therapy. Our study has shown that one more useful piece of information for the treatment of these patients, both for UF rate adjustment and intra-hemodialysis fluid administration, is now available with the use of BVM during IHD. A prospective randomized study is required to confirm our clinical observations. Fig. 1 . BVM evolution over time in critically ill children during IHD treatments (mean and SD). Upper rhombus: IHD treatment without hypotensive episodes (n ¼ 23), lower square: IHD treatment with hypotensive episodes (n ¼ 47). Dotted line at 13% decrease in BVM.
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